These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36714295)

  • 1. Impact of a Pharmacist-Managed Outpatient Parenteral Antimicrobial Therapy (OPAT) Service on Cost Savings and Clinical Outcomes at an Academic Medical Center.
    Epperson TM; Bennett KK; Kupiec KK; Speigel K; Neely SB; Resman-Targoff BH; Kinney KK; White BP
    Antimicrob Steward Healthc Epidemiol; 2023; 3(1):e15. PubMed ID: 36714295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-Administered Outpatient Antimicrobial Infusion by Uninsured Patients Discharged from a Safety-Net Hospital: A Propensity-Score-Balanced Retrospective Cohort Study.
    Bhavan KP; Brown LS; Haley RW
    PLoS Med; 2015 Dec; 12(12):e1001922. PubMed ID: 26671467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring of Outpatient Parenteral Antimicrobial Therapy and Implementation of Clinical Pharmacy Services at a Community Hospital Infusion Unit.
    Shah PJ; Bergman SJ; Graham DR; Glenn S
    J Pharm Pract; 2015 Oct; 28(5):462-8. PubMed ID: 25107418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of risk factors for readmission in patients receiving outpatient parenteral antimicrobial therapy.
    Bradley AC; Wingler MJB; Artman KL; Ward LM; Lucar J
    Ther Adv Infect Dis; 2023; 10():20499361231195966. PubMed ID: 37667754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased hospital readmissions after programmatic strengthening of an outpatient parenteral antimicrobial therapy (OPAT) program.
    Agnihotri G; Gross AE; Seok M; Yen CY; Khan F; Ebbitt LM; Gay C; Bleasdale SC; Sikka MK; Trotter AB
    Antimicrob Steward Healthc Epidemiol; 2023; 3(1):e33. PubMed ID: 36865701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of an Infectious Diseases Transition Service on the Care of Outpatients on Parenteral Antimicrobial Therapy.
    Keller SC; Ciuffetelli D; Bilker W; Norris A; Timko D; Rosen A; Myers JS; Hines J; Metlay J
    J Pharm Technol; 2013 Oct; 29(5):205-214. PubMed ID: 25621307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survey of pharmacists on their roles and perceptions of outpatient parenteral antimicrobial therapy in the United States.
    Rivera CG; Mara KC; Mahoney MV; Ryan KL
    Antimicrob Steward Healthc Epidemiol; 2022; 2(1):e69. PubMed ID: 36483442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of a multidisciplinary team review of potential outpatient parenteral antimicrobial therapy prior to discharge from an academic medical center.
    Heintz BH; Halilovic J; Christensen CL
    Ann Pharmacother; 2011 Nov; 45(11):1329-37. PubMed ID: 21990938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electronic health record-based readmission risk model performance for patients undergoing outpatient parenteral antibiotic therapy (OPAT).
    Drew R; Brenneman E; Funaro J; Lee HJ; Yarrington M; Dicks K; Gallagher D
    PLOS Digit Health; 2023 Aug; 2(8):e0000323. PubMed ID: 37531342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for readmission among patients receiving outpatient parenteral antimicrobial therapy: a retrospective cohort study.
    Douiyeb S; de la Court JR; Tuinte B; Sombogaard F; Schade RP; Kuijvenhoven M; Minderhoud T; Sigaloff KCE
    Int J Clin Pharm; 2022 Apr; 44(2):557-563. PubMed ID: 35157228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the implementation of a nurse-managed outpatient parenteral antibiotic therapy (OPAT) system in Baltimore: a case study demonstrating cost savings and reduction in re-admission rates.
    Mansour O; Heslin J; Townsend JL
    J Antimicrob Chemother; 2018 Nov; 73(11):3181-3188. PubMed ID: 30085088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outpatient Versus Inpatient Intravenous Antimicrobial Therapy: A Population-Based Observational Cohort Study of Adverse Events and Costs.
    Staples JA; Ho M; Ferris D; Hayek J; Liu G; Tran KC; Sutherland JM
    Clin Infect Dis; 2022 Nov; 75(11):1921-1929. PubMed ID: 35439822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of the first comprehensive outpatient parenteral antimicrobial therapy program in a tertiary care hospital in Japan.
    Hase R; Yokoyama Y; Suzuki H; Uno S; Mikawa T; Suzuki D; Muranaka K; Hosokawa N
    Int J Infect Dis; 2020 Jun; 95():210-215. PubMed ID: 32205285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementing the First Outpatient Parenteral Antimicrobial Therapy (OPAT) Program to Utilize Disposable Elastomeric Pumps in the Gulf Region: Results From a Tertiary Teaching Hospital in the Kingdom of Saudi Arabia.
    Zikri A; Al-Faraj H; Kamas N; AlZahrani J; BuKhamseen H; Alshahoub W; Beltran A; Fatih D; AlMusa Z
    Cureus; 2021 Dec; 13(12):e20179. PubMed ID: 34900504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and implementation of a pharmacist-managed outpatient parenteral antimicrobial therapy program.
    Chung EK; Beeler CB; Muloma EW; Osterholzer D; Damer KM; Erdman SM
    Am J Health Syst Pharm; 2016 Jan; 73(1):e24-33. PubMed ID: 26683676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Inpatient Antimicrobial Regimens for Readmitted Outpatient Parenteral Antimicrobial Therapy Patients Receiving Daptomycin or Ertapenem for Ease of Administration.
    Britt RS; LaSalvia MT; Padival S; Patel P; McCoy C; Mahoney MV
    Open Forum Infect Dis; 2019 Dec; 6(12):ofz496. PubMed ID: 32128338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the utilization and impact of a newly established outpatient parenteral antimicrobial therapy (OPAT) program.
    Yan M; Lam PW; Andany N; Chan AK; Leis JA; Mubareka S; Simor AE; Daneman N
    J Assoc Med Microbiol Infect Dis Can; 2020 Jun; 5(2):70-76. PubMed ID: 36338181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse events, healthcare interventions and healthcare utilization during home infusion therapy with daptomycin and vancomycin: a propensity score-matched cohort study.
    Shrestha NK; Mason P; Gordon SM; Neuner E; Nutter B; O'Rourke C; Rehm SJ
    J Antimicrob Chemother; 2014 May; 69(5):1407-15. PubMed ID: 24398341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluate the Effectiveness of Outpatient Parenteral Antimicrobial Therapy (OPAT) Program in Saudi Arabia: A Retrospective Study.
    Al Shareef HJ; Al Harbi A; Alatawi Y; Aljabri A; Al-Ghanmi MA; Alzahrani MS; Algarni MA; Khobrani A; Haseeb A; AlSenani F; Elrggal ME
    Antibiotics (Basel); 2022 Mar; 11(4):. PubMed ID: 35453192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Close Patient Follow-up Among Patients Receiving Outpatient Parenteral Antimicrobial Therapy.
    Palms DL; Jacob JT
    Clin Infect Dis; 2020 Jan; 70(1):67-74. PubMed ID: 30810165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.